Biological significance of miR-126 expression in atrial fibrillation and heart failure

Biological significance of miR-126 expression in atrial fibrillation and heart failure

We investigated the biological significance of microRNA-126 (miR-126) expression in patients with atrial fibrillation (AF) and/or heart failure (HF) to examine the possible mechanism of miR-126-dependent AF and development of HF. A total of 103 patients were divided into three groups: AF group (18 m...

Full description

Bibliographic Details
Main Authors:	X.J. Wei, M. Han, F.Y. Yang, G.C. Wei, Z.G. Liang, H. Yao, C.W. Ji, R.S. Xie, C.L. Gong, Y. Tian
Format:	Article
Language:	English
Published:	Associação Brasileira de Divulgação Científica 2015-08-01
Series:	Brazilian Journal of Medical and Biological Research
Subjects:	MicroRNA-126 Atrial fibrillation Heart failure Heart function indices N-terminal prohormone brain natriuretic peptide (NT-proBNP)
Online Access:	http://www.scielo.br/pdf/bjmbr/v48n11/1414-431X-bjmbr-1414-431X20154590.pdf

Similar Items

Risk Factors of Sudden Cardiac Arrest during the Postoperative Period in Patient Undergoing Heart Valve Surgery
by: Piotr Duchnowski
Published: (2022-11-01)

Performance of the Abbott Architect Immuno-Chemiluminometric NT-proBNP Assay
by: Chin-Shern Lau, et al.
Published: (2022-05-01)

Usefulness of the N-Terminal of the Prohormone Brain Natriuretic Peptide in Predicting Acute Kidney Injury Requiring Renal Replacement Therapy in Patients Undergoing Heart Valve Surgery
by: Piotr Duchnowski, et al.
Published: (2023-11-01)

Elevated Serotonin and NT-proBNP Levels Predict and Detect Carcinoid Heart Disease in a Large Validation Study
by: Sonja Levy, et al.
Published: (2022-05-01)

Diagnosing heart failure in primary care: individual patient data meta‐analysis of two European prospective studies
by: Andrea K. Roalfe, et al.
Published: (2021-06-01)

A Differential Profile of Biomarkers between Patients with Atrial Fibrillation and Healthy Controls
by: Ana Merino-Merino, et al.
Published: (2022-08-01)

Six-Month Predictive Value of Diuretic Resistance Formulas in Discharged Heart Failure Patients after an Acute Decompensation
by: Mauro Feola, et al.
Published: (2020-09-01)

Differences According to Age in the Diagnostic Performance of Cardiac Biomarkers to Predict Frailty in Patients with Acute Heart Failure
by: Lara Aguilar-Iglesias, et al.
Published: (2022-02-01)

Heart failure with preserved ejection fraction in haemodialysis patients: prevalence, diagnosis, risk factors, prognosis
by: Xixi Yu, et al.
Published: (2023-10-01)

Effect of body mass index on N-terminal pro-brain natriuretic peptide values in patients with heart failure
by: Tuan Ha Manh, et al.
Published: (2023-08-01)

Serum Pro‐N‐Cadherin Is a Marker of Subclinical Heart Failure in the General Population
by: Paul Durham Ferrell, et al.
Published: (2023-03-01)

Vericiguat and NT‐proBNP in patients with heart failure with reduced ejection fraction: analyses from the VICTORIA trial
by: Michele Senni, et al.
Published: (2022-12-01)

Development of a Rapid Diagnostic Kit for Congestive Heart Failure Using Recombinant NT-proBNP Antigen
by: Young-Ki Lee, et al.
Published: (2021-07-01)

Role of NT-proBNP and lung ultrasound in diagnosing and classifying heart failure in a hospitalized oldest-old population: a cross-sectional study
by: Matteo Landolfo, et al.
Published: (2024-04-01)

Mediterranean Diet, Vitamin D, and Hypercaloric, Hyperproteic Oral Supplements for Treating Sarcopenia in Patients with Heart Failure—A Randomized Clinical Trial
by: Aura D. Herrera-Martínez, et al.
Published: (2023-12-01)

Investigating the Role of Brain Natriuretic Peptide (BNP) and N-Terminal-proBNP in Thrombosis and Acute Ischemic Stroke Etiology
by: Rosanna Rossi, et al.
Published: (2024-03-01)

Urinary N‐terminal pro‐brain natriuretic peptide: prognostic value in patients with acute chest pain
by: Stefanie Reynen, et al.
Published: (2021-06-01)

NT-ProBNP and mortality across the spectrum of glucose tolerance in the general US population
by: Stefano Ciardullo, et al.
Published: (2022-11-01)

Brain–Heart Axis and Biomarkers of Cardiac Damage and Dysfunction after Stroke: A Systematic Review and Meta-Analysis
by: Chengyang Xu, et al.
Published: (2020-03-01)

Higher BNP/NT‐pro BNP levels stratify prognosis equally well in patients with and without heart failure: a meta‐analysis
by: Stefanie Hendricks, et al.
Published: (2022-10-01)

Usefulness of NT-proBNP in dogs with heartworm: could this biomarker be useful to evaluate pulmonary hypertension?
by: Noelia Costa-Rodríguez, et al.
Published: (2023-08-01)

Development of an NT-ProBNP Assay Reagent Based on High Specific Activity Alkaline Phosphatase CmAP and an Improved Coupling Method
by: Hai-Chao Li, et al.
Published: (2020-12-01)

The serum soluble scavenger with 5 domains levels: A novel biomarker for individuals with heart failure
by: Yulong Ge, et al.
Published: (2023-04-01)

Correlation of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) with radiographic features of congestion in chest CT scan of patients with COVID-19
by: Naghmeh Ziaie, et al.
Published: (2023-07-01)

N-TerminalPro-B-TypeNatriuretic Peptide For Detecting Early Cardiac Dysfunction in Patients with Thyroid Dysfunction
by: Makbule Ulusoy, et al.
Published: (2013-09-01)

Sex and N-terminal pro B-type natriuretic peptide: The potential mediating role of iron biomarkers
by: Farnaz Khatami, et al.
Published: (2022-11-01)

Correlation of NT-proBNP levels with clinical and echocardiographic features in evaluation of patients admitted with heart failure
by: Dhinakaran K, et al.
Published: (2023-12-01)

Assessment of the Relationship between Periodontitis and Cardiac Parameters in Patients with Early Chronic Heart Failure: A Cross-Sectional Study
by: Antina Schulze, et al.
Published: (2024-03-01)

ECG and Biomarker Profile in Patients with Acute Heart Failure: A Pilot Study
by: Adriana Chetran, et al.
Published: (2022-12-01)

The cost‐effectiveness of NT‐proBNP for assessment of suspected acute heart failure in the emergency department
by: Ryan Walkley, et al.
Published: (2023-12-01)

Diabetes mellitus status modifies the association between N-terminal B-type natriuretic peptide and all-cause mortality risk in ischemic heart failure: a prospective cohort study
by: Weida Qiu, et al.
Published: (2023-04-01)

Effect of thyroid dysfunction on N-terminal pro-B-type natriuretic peptide levels: A systematic review and meta-analysis
by: Hongling Zhang, et al.
Published: (2023-01-01)

miR−21 and NT-proBNP Correlate with Echocardiographic Parameters of Atrial Dysfunction and Predict Atrial Fibrillation
by: Jan-Thorben Sieweke, et al.
Published: (2020-04-01)

Aortic Root Remodeling as an Indicator for Diastolic Dysfunction and Normative Ranges in Asians: Comparison and Validation with Multidetector Computed Tomography
by: Lawrence Yu-min Liu, et al.
Published: (2020-09-01)

N terminal prohormone of brain natriuretic peptide is associated with improved heart rate recovery after treadmill exercise test
by: Yi-Ting Lin, et al.
Published: (2023-09-01)

The Potential Role of Salivary NT-proBNP in Heart Failure
by: Aidonis Rammos, et al.
Published: (2023-08-01)

Impact of HIF prolyl hydroxylase inhibitors in heart failure patients with renal anemia
by: Takahiro Kambara, et al.
Published: (2024-03-01)

N‐terminal pro‐B‐type natriuretic peptide concentrations, testing and associations with worsening heart failure events
by: Giulia Ferrannini, et al.
Published: (2024-04-01)

Comparing the Effects of Canagliflozin vs. Glimepiride by Body Mass Index in Patients with Type 2 Diabetes and Chronic Heart Failure: A Subanalysis of the CANDLE Trial
by: Akira Sezai, et al.
Published: (2022-07-01)

Value of NT-proBNP and Galectin-3 as Biomarkers in the Follow-Up of Asymptomatic Elderly Patients with Severe Aortic Stenosis
by: Mónica Ramos, et al.
Published: (2023-04-01)